Pain points: Unsolved recruitment and trial design issues in pain clinical trials
Although pain affects millions of people worldwide, the industry is still struggling in the ongoing search for safe and effective medication.

Although pain affects millions of people worldwide, the industry is still struggling in the ongoing search for safe and effective medication.
As part of the BARDA contract, Gritstone bio will launch a Phase IIb vaccine trial enrolling 10,000 subjects.
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Medidata unveils new solution to boost clinical trial diversity
Corporate sustainability needs ESG standards and tools
Invivyd doses first patient in Covid-19 therapy trial
Is long Covid linked to Alzheimer’s disease?